| Bioactivity | PRDX3(103-112) SO3 modified, human is a marker of ferroptosis, and can be used for liver diseases study[1]. |
| Name | PRDX3(103-112) SO3 modified, human |
| CAS | 847447-04-5 |
| Sequence | Asp-Phe-Thr-Phe-Val-{Cys(SO3H)}-Pro-Thr-Glu-Ile |
| Shortening | DFTFV-{Cys(SO3H)}-PTEI |
| Formula | C54H78N10O20S |
| Molar Mass | 1219.32 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cui S, et al. Identification of hyperoxidized PRDX3 as a ferroptosis marker reveals ferroptotic damage in chronic liver diseases. Mol Cell. 2023;83(21):3931-3939.e5. |
PRDX3(103-112) SO3 modified, human
CAS: 847447-04-5 F: C54H78N10O20S W: 1219.32
PRDX3(103-112) SO3 modified, human is a marker of ferroptosis, and can be used for liver diseases study.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.